A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2011
10/27/2011	WO2011130908A1 Substituted pyrimidines
10/27/2011	WO2011062436A3 Composition for improving blood circulation, containing extract of lindera obtusiloba as active ingredient
10/27/2011	WO2002023190A8 Methods and products related to low molecular weight heparin
10/27/2011	US20110263704 Methods of Using Cycloalkylmethylamines
10/27/2011	US20110263690 Methods and Compositions for use in Gene Therapy for Treatment of Hemophilia
10/27/2011	US20110263668 Beta 3-Adrenoreceptor Agonists for the Treatment of Cardiac Hypertrophy and Heart Failure
10/27/2011	US20110263594 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
10/27/2011	US20110263593 NOVEL IMIDAZO[1,2-a]PYRIMIDINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE, IN PARTICULAR AS MET INHIBITORS
10/27/2011	US20110263592 Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
10/27/2011	US20110263589 Method for preventing or treating a glucocorticoid receptor-related disease
10/27/2011	US20110263579 Chlorothiazide, chlorothiazide salts and pharmaceutical compositions thereof
10/27/2011	US20110263575 Compounds Useful as Protein Kinase Inhibitors
10/27/2011	US20110263549 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
10/27/2011	US20110263544 1-Phenylpyrrole Derivatives
10/27/2011	US20110263541 Kinase inhibitors and their use as pharmaceutical agents
10/27/2011	US20110263539 Ship 1 modulator compounds
10/27/2011	US20110263527 Sulfated Galactans With Antithrombotic Activity, Pharmaceutical Composition, Method for Treating or Prophylaxis of Arterial or Venous Thrombosis, Method of Extraction and Use Thereof
10/27/2011	US20110263503 Treatment of bleeding with low half-life fibrinogen
10/27/2011	US20110263494 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf-kappab acitivity and use thereof
10/27/2011	US20110263492 Method to generate water soluble or nonwater soluble in nanoparticulates directly in suspension of dispersion media
10/27/2011	US20110263482 Complement inhibitors
10/27/2011	US20110263027 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
10/27/2011	US20110262555 Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
10/27/2011	US20110262548 Novel prostaglandin e1 derivative and nanoparticle having the same encapsulated therein
10/27/2011	US20110262466 Compositions containing thrombomodulin domains and uses thereof
10/27/2011	US20110262424 Recombinantly produced human factor viii and ix
10/27/2011	US20110262419 Specifically targeted catalytic antagonists and uses thereof
10/27/2011	US20110262386 Methods of treating inflammation
10/27/2011	US20110262380 Theapeutic use of protein-polymer conjugates
10/27/2011	US20110262379 Maleamic Acid Polymer Derivatives and Their Bioconjugates
10/26/2011	EP2380877A1 Pyridine-3-carboxyamide derivative
10/26/2011	EP2380435A2 Feline-derived protein and method for production thereof
10/26/2011	EP2379600A1 Antibodies against tissue factor pathway inhibitor
10/26/2011	EP2379599A1 Antibodies against tissue factor pathway inhibitor (tfpi)
10/26/2011	EP2379562A1 Bicyclic pyranone derivatives as nicotinic acid receptor agonists
10/26/2011	EP2150561B1 Demannosylated recombinant factor VIII for the treatment of patients with haemophilia A
10/26/2011	EP1996626B1 Anti-idiotypic antibody which neutralizes the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii
10/26/2011	EP1425010B1 Substituted indoles and their use as integrin antagonists
10/26/2011	CN102227409A Pyridine-3-carboxyamide derivative
10/26/2011	CN102227223A Mineral absorption improver, and method for improving absorption of minerals
10/26/2011	CN102225965A Substituted tetrahydro-isoquinoline-3-carboxylic acid compound, preparation method and application thereof
10/26/2011	CN102225940A Isosorbide benzoate compound as well as preparation method and medicinal use thereof
10/26/2011	CN102225923A Method for preparing dihydromyricetin from Ampelopsis grossedentata
10/26/2011	CN102225202A Compound preparation containing aspirin and proton pump inhibitor
10/26/2011	CN102225194A Use of Bv8 and/or EG-VEGF to promote hematopoiesis
10/26/2011	CN102225162A Medicine for enhancing leukocyte and thrombocyte of human body
10/26/2011	CN102225157A Plaster for relieving pain, stopping haemorrhage and diminishing swelling
10/26/2011	CN102225135A Traditional Chinese medicine hemostasis powder for external use
10/26/2011	CN102225048A Curcumin compound injection and intravenous injection preparation thereof
10/26/2011	CN101851339B Method for preparing donkey skin collagens
10/26/2011	CN101664543B Hemokinin-iron oral liquid
10/26/2011	CN101618172B Traditional Chinese medicine for treating hepatitis B, cirrhosis, liver cancer and liver ascites
10/26/2011	CN101585863B Method for preparing yamogenin
10/26/2011	CN101525598B Method for purifying human urinary trypsin inhibitor
10/26/2011	CN101386596B 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators
10/26/2011	CN101348761B Health care wine
10/25/2011	US8044182 Adiponectin and uses thereof
10/25/2011	US8044174 Thrombopoietic compounds
10/25/2011	US8044070 Heteroaryloxy nitrogenous saturated heterocyclic derivative
10/25/2011	US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/25/2011	US8043629 Bioabsorbable synthetic nonwoven fabric holding thrombin
10/20/2011	WO2011130479A2 Application of polymeric materials to screens to facilitate hemostasis and wound healing
10/20/2011	WO2011129796A1 5,11,17,23-tetrakis[bis(dihydroxyphosphoryl)methyl]calix[4]arene or the na salt thereof as fibrin polymerization inhibitors
10/20/2011	WO2011128421A1 Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors
10/20/2011	WO2011127625A1 Method for regulating microrna content in organisms and uses thereof
10/20/2011	WO2011056978A3 S isomers of alpha-methyl hydrocinnamic acid for the treatment of blood disorders
10/20/2011	WO2011038157A3 Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins
10/20/2011	US20110258713 Compositions and methods for re-programming cells without genetic modification
10/20/2011	US20110257252 Novel antithrombotic diadenosine tetraphosphates and related analogs
10/20/2011	US20110257244 Chemically modified oligonucleotides and small molecules for use in reducing micro rna activity levels and uses thereof
10/20/2011	US20110257171 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors
10/20/2011	US20110257132 Charged phospholipid compositions and methods for their use
10/20/2011	US20110257124 Esterified Polysaccharide Osmotics
10/20/2011	US20110257090 Solutions for volume therapy
10/20/2011	US20110256229 Rapid-acting pharmaceutical composition
10/20/2011	US20110256225 Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same
10/20/2011	US20110256130 Methods of treating inflammatory disorders
10/20/2011	US20110256126 IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof
10/20/2011	US20110256117 Manufacturing and use of composite scaffolds
10/20/2011	US20110256092 Quinoline derivatives for modulating dna methylation
10/20/2011	DE102010015242A1 Kombination aus Vitamin K und Nikotinamid Combination of vitamin K and nicotinamide
10/19/2011	EP2376475A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
10/19/2011	EP2376425A2 Kinase inhibitor compounds
10/19/2011	EP2376096A2 Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus
10/19/2011	EP2376065A2 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof
10/19/2011	EP1967195B1 Antacid
10/19/2011	EP1372735B1 Conjugate of hydroxyalkyl starch and an active agent
10/19/2011	CN102223884A Solid pharmaceutical composition
10/19/2011	CN102220258A Bacillus subtilis generating nattokinase and method for producing nattokinase by fermenting same
10/19/2011	CN102220216A Acanthopanax sessiliflorus white spirit and brewing method thereof
10/19/2011	CN102219853A Anti-H5N1 type bird flue virus vicuna VHH heavy chain antibody as well as preparation method and application thereof
10/19/2011	CN102219727A Synthesis method of compound indometacin-feruloyl esterase
10/19/2011	CN102219724A Pyrrolidone compound as well as preparation method and applications thereof
10/19/2011	CN102218144A Method for regulating content of micro-ribonucleic acids in organism and use thereof
10/19/2011	CN102218132A Medicinal composition for treating nasal bleeding
10/19/2011	CN102218080A High-speed filtration preparation process of polypeptide donkey-skin gelatin plasma substitutes
10/19/2011	CN102218058A Application of sparstolenin B as TLR2 (Toll-like receptor 2)/TLR4 (Toll-like receptor 4) antagonist in pharmacy
10/19/2011	CN102218043A LDH (Layered Double Hydroxides) supermolecular assembly type aspirin sustained release tablet and preparation method thereof
10/19/2011	CN101785782B Long-circulating ligustrazine composite injection and preparation method thereof
10/19/2011	CN101756912B Hemocoagulase freeze-dried powder injection and preparation method thereof

1 ... 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 ... 671